Androgen deprivation therapy - one of the most common treatments for prostate cancer - may increase the risk of death from heart disease// in patients over age 65, according to a new study.
The study results were based on data from CaPSURE, a national registry of men with prostate cancer. Although the findings need to be confirmed in clinical trials, the study authors state that oncologists should weigh the benefits of androgen deprivation therapy, or ADT, against the risk of heart problems in older prostate cancer patients.
The goal of ADT is to block the level of circulating androgens (male hormones), which can fuel the growth of prostate cancers. "Androgen deprivation therapy is associated with elevated body mass index, increased body fat deposits and diabetes, all of which raise the risk of death from heart diseased," explains the study's lead author, Henry Tsai, MD, a resident physician at Dana-Farber, Brigham and Women's and the Harvard Radiation Oncology Program.
"Although our findings demonstrated that older men receiving this treatment may be at increased risk, even after taking into account other cardiovascular risk factors, a prospective clinical trial would be needed to confirm a cause-and-effect relationship."
Drawing on the CaPSURE database, Tsai and his colleagues compared the number of cardiac-related deaths among 735 men with localized prostate cancer who received ADT and among 2,901 men with the disease whose treatment did not include ADT.
After factoring in other known risks for cardiovascular disease (such as diabetes, hypertension, body mass index and smoking), researchers found that the longer patients received ADT, the sooner they were likely to die from heart disease. When the researchers analyzed the data by patients' age, the link between ADT use and death from heart disease was significant in patients over age 65, but not in those under 65. After five years, 3 percent of older mePage: 1 2 Related medicine news :1
. Cancer Doctors Okays Controversial Prostate Therapy2
. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body3
. New Prostate Cancer Vaccine Shows Promise4
. Hormone Therapy applicable for Prostate Cancer5
. Prostate cancer and Vitamins 6
. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time7
. Early Detection Of Prostate Cancer8
. Awareness increase Prostate cancer detection9
. Better Prostate Cancer Test10
. Stopping Prostate Cancer from Spreading11
. Drug might prevent Prostate Cancer Spread